Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Cowen & Co. Downgrades Fate Therapeutics to Market Perform

Cowen & Co. analyst Tyler Van Buren downgrades Fate Therapeutics (NASDAQ:FATE) from Outperform to Market Perform.
byBenzinga Newsdesk
January 6, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Cowen & Co. analyst Tyler Van Buren downgrades Fate Therapeutics (NASDAQ:FATE) from Outperform to Market Perform.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

EXCLUSIVE: Cannabis Industry Experts Share Insights On Building Customer Loyalty – ‘It’s All About Education’

By Joana Scopel
April 11, 5:37 PM
A panel of experts discussed how cannabis companies are targeting retail customers, at the Benzinga Cannabis Capital Conference in Miami Beach on Tuesday. The panel shared tips and tricks on what businesses should be doing to engage and keep their customers coming back for more.

GTBIF